These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38779721)

  • 1. Checkpoint inhibition enhances cell contacts between CD4
    Yadigaroglu K; Scharf S; Gretser S; Schäfer H; Deli ASS; Loth AG; Yegoryan H; Schmitz R; Donnadieu E; Hansmann ML; Hartmann S
    Haematologica; 2024 Oct; 109(10):3295-3304. PubMed ID: 38779721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital spatial profiling of CD4
    Takeuchi M; Miyoshi H; Semba Y; Yamada K; Nakashima K; Sato K; Furuta T; Moritsubo M; Ogura Y; Tanaka K; Imamoto T; Arakawa F; Kohno K; Ohshima K
    Virchows Arch; 2023 Aug; 483(2):255-260. PubMed ID: 37270432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.
    Roemer MGM; Redd RA; Cader FZ; Pak CJ; Abdelrahman S; Ouyang J; Sasse S; Younes A; Fanale M; Santoro A; Zinzani PL; Timmerman J; Collins GP; Ramchandren R; Cohen JB; De Boer JP; Kuruvilla J; Savage KJ; Trneny M; Ansell S; Kato K; Farsaci B; Sumbul A; Armand P; Neuberg DS; Pinkus GS; Ligon AH; Rodig SJ; Shipp MA
    J Clin Oncol; 2018 Apr; 36(10):942-950. PubMed ID: 29394125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reed-Sternberg cell-derived lymphotoxin-α activates endothelial cells to enhance T-cell recruitment in classical Hodgkin lymphoma.
    Fhu CW; Graham AM; Yap CT; Al-Salam S; Castella A; Chong SM; Lim YC
    Blood; 2014 Nov; 124(19):2973-82. PubMed ID: 25139349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.
    Reinke S; Bröckelmann PJ; Iaccarino I; Garcia-Marquez M; Borchmann S; Jochims F; Kotrova M; Pal K; Brüggemann M; Hartmann E; Sasse S; Kobe C; Mathas S; Soekler M; Keller U; Bormann M; Zimmermann A; Richter J; Fuchs M; von Tresckow B; Borchmann P; Schlößer H; von Bergwelt-Baildon M; Rosenwald A; Engert A; Klapper W
    Blood; 2020 Dec; 136(25):2851-2863. PubMed ID: 33113552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4-positive T cells that are PD-1-negative.
    Patel SS; Weirather JL; Lipschitz M; Lako A; Chen PH; Griffin GK; Armand P; Shipp MA; Rodig SJ
    Blood; 2019 Dec; 134(23):2059-2069. PubMed ID: 31697809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
    Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
    Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D connectomes of reactive and neoplastic CD30 positive lymphoid cells and surrounding cell types.
    Lumer L; Wurzel P; Scharf S; Schäfer H; Ackermann J; Koch I; Hansmann ML
    Acta Histochem; 2021 Jul; 123(5):151750. PubMed ID: 34233254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplexed Spatial Profiling of Hodgkin Reed-Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma.
    Pourmaleki M; Jones CJ; Mellinghoff SD; Greenstein BD; Kumar P; Foronda M; Navarrete DA; Campos C; Roshal M; Schultz N; Shah SP; Schietinger A; Socci ND; Hollmann TJ; Dogan A; Mellinghoff IK
    Clin Cancer Res; 2024 Sep; 30(17):3881-3893. PubMed ID: 38949890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma.
    Carey CD; Gusenleitner D; Lipschitz M; Roemer MGM; Stack EC; Gjini E; Hu X; Redd R; Freeman GJ; Neuberg D; Hodi FS; Liu XS; Shipp MA; Rodig SJ
    Blood; 2017 Nov; 130(22):2420-2430. PubMed ID: 28893733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes.
    Nagpal P; Descalzi-Montoya DB; Lodhi N
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1311. PubMed ID: 33103852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma.
    Aoki T; Chong LC; Takata K; Milne K; Marshall A; Chavez EA; Miyata-Takata T; Ben-Neriah S; Unrau D; Telenius A; Boyle M; Weng AP; Savage KJ; Scott DW; Farinha P; Shah SP; Nelson BH; Steidl C
    Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34615710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nivolumab in the Treatment of Hodgkin Lymphoma.
    Ansell SM
    Clin Cancer Res; 2017 Apr; 23(7):1623-1626. PubMed ID: 27881581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses.
    Chen X; Yu J; Venkataraman G; Smith SM; Chen M; Cooper A; Tumuluru S; Brody JD; Godfrey J; Kline J
    Cancer Immunol Res; 2024 Mar; 12(3):296-307. PubMed ID: 38240659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment.
    Ferrarini I; Rigo A; Zamò A; Vinante F
    Leuk Lymphoma; 2019 Dec; 60(14):3395-3405. PubMed ID: 31304817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 induces Reed-Sternberg cell-like morphology and chromosomal instability in classic Hodgkin lymphoma cell lines.
    Watanabe M; Hatsuse H; Nagao K; Nakashima M; Uchimaru K; Otsu M; Miyazaki K; Horie R
    Cancer Sci; 2023 Aug; 114(8):3433-3445. PubMed ID: 37302818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma.
    Steidl C; Diepstra A; Lee T; Chan FC; Farinha P; Tan K; Telenius A; Barclay L; Shah SP; Connors JM; van den Berg A; Gascoyne RD
    Blood; 2012 Oct; 120(17):3530-40. PubMed ID: 22955918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.
    Lyapichev KA; You MJ; Vega F; Solis LM; Medeiros LJ
    Virchows Arch; 2020 Sep; 477(3):437-444. PubMed ID: 32152665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BET inhibitors induce NF-κB and E2F downregulation in Hodgkin and Reed-Sternberg cells.
    Fernández S; Díaz E; Rita CG; Estévez M; Montalbán C; García JF
    Exp Cell Res; 2023 Sep; 430(2):113718. PubMed ID: 37468057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
    Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
    Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.